Signal2026-07-27
ClinicalTrials.gov

[PHASE2] Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceSee the whole picture